Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Alternatives · BNY Mellon / Dreyfus

BNY Mellon Mid Cap Multi-Strategy Fund Class M Shares (MPMCX)

Ticker MPMCX ·

Expense ratio
0.95%$95/yr per $10k
5-yr return
+9.3%annualized
1-yr return
+12.7%as of Dec 2024

Bottom line

Is MPMCX a good fund? The bottom line

MPMCX is the Class M share class of BNY Mellon Mid Cap Multi-Strategy Fund, a managed alternatives mutual fund from BNY Mellon / Dreyfus.

Its expense ratio is 0.95% — about $95 a year on every $10,000 invested, cheaper than 81% of alternatives funds we track.

It returned +12.7% over one year, +9.3% a year over five years, +9.3% a year over ten (as of Dec 31, 2024, per its prospectus).

What stands out

  • Low cost: cheaper than 81% of alternatives peers
  • 5-year return beat 86% of category peers

Updated Nov 19, 2026

What MPMCX invests in

The fund seeks capital appreciation.

"To pursue its goal, the fund normally invests at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities of mid cap companies. The fund currently considers mid cap companies to be those companies with market capitalizations that are within the market capitalization range of companies comprising the Russell Midcap Index. As of November 30, 2025, the market capitalizations of the largest and smallest companies in the Russell Midcap Index were approximately $114.5 billion and $1.0 billion, respectively, and the weighted average and median market capitalizations of the index were approximately $30.7 billion and $12.3 billion, respectively. The fund normally allocates its assets among multiple investment strategies employed by BNY Mellon Investment Adviser, Inc. (BNYIA) and affiliated and unaffiliated sub-advisers that invest primarily in equity…

From the fund's prospectus (filed Dec 29, 2025).

MPMCX performance

Fund calendar-year total returns, 2015–2024 2015: −2.7%; 2016: +11.6%; 2017: +18.7%; 2018: −9.0%; 2019: +30.8%; 2020: +22.9%; 2021: +19.2%; 2022: −18.4%; 2023: +17.9%; 2024: +12.7% −3% 2015 +12% 2016 +19% 2017 −9% 2018 +31% 2019 +23% 2020 +19% 2021 −18% 2022 +18% 2023 +13% 2024
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
MPMCX+12.7%+9.3%+9.3%
Alternatives median+7.4%+4.2%+3.8%

Source: Fund prospectus, as of Dec 31, 2024

Full MPMCX performance history →

What MPMCX costs

On a $10,000 investment, MPMCX's 0.95% expense ratio costs about $95 a year. The prospectus estimates $1,166 in total costs over 10 years (assuming 5% annual returns). The median alternatives fund charges 1.54%.

See the full MPMCX fee table →

Alternatives to MPMCX

More funds like MPMCX →

MPMCX FAQ

What is the expense ratio of MPMCX?
MPMCX's expense ratio is 0.95%, which works out to about $95 a year for every $10,000 invested. The prospectus estimates total costs of $1,166 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is MPMCX a good investment?
It depends on your goals, but the data points to: low cost: cheaper than 81% of alternatives peers; 5-year return beat 86% of category peers. This is general information, not personalized advice.
What is MPMCX's 5-year return?
MPMCX returned +9.3% a year over the five years ending Dec 31, 2024, and +9.3% a year over ten years. Past performance does not guarantee future results.
Who manages MPMCX?
MPMCX is offered by BNY Mellon / Dreyfus through Bny Mellon Funds Trust.